This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2007 Feb;85(1):118-9.

doi: 10.1111/j.1600-0420.2006.00850.x.

Intravitreal bevacizumab for branch retinal vein occlusion

Ulrich Spandau, Anne Wickenhäuser, Florian Rensch, Jost Jonas

PMID: 17244225
DOI: 10.1111/j.1600-0420.2006.00850.x

Free article

Case Reports

Intravitreal bevacizumab for branch retinal vein occlusion

Ulrich Spandau et al. Acta Ophthalmol Scand. 2007 Feb.

Free article

. 2007 Feb;85(1):118-9.

doi: 10.1111/j.1600-0420.2006.00850.x.

Authors

Ulrich Spandau, Anne Wickenhäuser, Florian Rensch, Jost Jonas

PMID: 17244225
DOI: 10.1111/j.1600-0420.2006.00850.x

No abstract available

PubMed Disclaimer

Similar articles

Comment of article by Matsumoto Y.
Campa C, D'Angelo S, Incorvaia C. Campa C, et al. Retina. 2008 May;28(5):782; author reply 782-3. doi: 10.1097/IAE.0b013e31816a559a. Retina. 2008. PMID: 18463528 No abstract available.
Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion.
Parveen S, Narayanan R, Sambhav K, Bhatia K. Parveen S, et al. Retina. 2010 Sep;30(8):1324-5; author reply 1325. doi: 10.1097/IAE.0b013e3181e723c7. Retina. 2010. PMID: 20827152 No abstract available.
Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease.
Matsumoto Y, Freund KB, Peiretti E, Cooney MJ, Ferrara DC, Yannuzzi LA. Matsumoto Y, et al. Retina. 2007 Apr-May;27(4):426-31. doi: 10.1097/IAE.0b013e31804a7af2. Retina. 2007. PMID: 17420693
The treatment of branch retinal vein occlusion with bevacizumab.
Badalà F. Badalà F. Curr Opin Ophthalmol. 2008 May;19(3):234-8. doi: 10.1097/ICU.0b013e3282fb7fb0. Curr Opin Ophthalmol. 2008. PMID: 18408499 Review.
Bevacizumab (avastin) in ocular processes other than choroidal neovascularization.
Barkmeier AJ, Akduman L. Barkmeier AJ, et al. Ocul Immunol Inflamm. 2009 Mar-Apr;17(2):109-17. doi: 10.1080/09273940802596534. Ocul Immunol Inflamm. 2009. PMID: 19412873 Review.

See all similar articles

Cited by

Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities.
Rehak J, Rehak M. Rehak J, et al. Curr Eye Res. 2008 Feb;33(2):111-31. doi: 10.1080/02713680701851902. Curr Eye Res. 2008. PMID: 18293182 Free PMC article. Review.
Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study.
Moschos MM, Moschos M. Moschos MM, et al. Doc Ophthalmol. 2008 Mar;116(2):147-52. doi: 10.1007/s10633-007-9110-9. Epub 2008 Jan 10. Doc Ophthalmol. 2008. PMID: 18189152
Early Avastin management in acute retinal vein occlusion.
Mehany SA, Mourad KM, Shawkat AM, Sayed MF. Mehany SA, et al. Saudi J Ophthalmol. 2010 Jul;24(3):87-94. doi: 10.1016/j.sjopt.2010.03.004. Epub 2010 Apr 4. Saudi J Ophthalmol. 2010. PMID: 23960882 Free PMC article.
Erectile dysfunction following intravitreal bevacizumab.
Yohendran J, Chauhan D. Yohendran J, et al. Middle East Afr J Ophthalmol. 2010 Jul;17(3):281-4. doi: 10.4103/0974-9233.65497. Middle East Afr J Ophthalmol. 2010. PMID: 20844689 Free PMC article.
Electrophysiological and structural assessment of the central retina following intravitreal injection of bevacizumab for treatment of macular edema.
Shetty R, Pai SA, Vincent A, Shetty N, Narayana KM, Sinha B, Shetty BK. Shetty R, et al. Doc Ophthalmol. 2008 Mar;116(2):129-35. doi: 10.1007/s10633-007-9090-9. Epub 2007 Oct 25. Doc Ophthalmol. 2008. PMID: 17960440

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley